5-Bromo-1,2,3,4-tetrahydro-1,7-naphthyridine

Catalog No. :
ACHBIM327
CAS No. :
351457-97-1
Molecular Formula :
C8H9BrN2
Molecular Weight :
213.08

IUPAC Name:5-bromo-1,2,3,4-tetrahydro-1,7-naphthyridine

5-Bromo-1,2,3,4-tetrahydro-1,7-naphthyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$470.00Login to see priceIn stockInquiry
250mg97%$783.00Login to see priceIn stockInquiry
500mg97%$1305.00Login to see priceIn stockInquiry
1g97%$1957.00Login to see priceIn stockInquiry
5g97%$5871.00Login to see priceIn stockInquiry
10g97%$9785.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-1,2,3,4-tetrahydro-1,7-naphthyridine
IUPAC Name5-bromo-1,2,3,4-tetrahydro-1,7-naphthyridine
MDL No.MFCD11518971
Molecular FormulaC8H9BrN2
Molecular Weight213.08
SMILESBrC1=C2CCCNC2=CN=C1
InChI KeyWBDFPECBTFVBDX-UHFFFAOYSA-N
SynonymDTXSID90625165 | 5-BROMO-1,2,3,4-TETRAHYDRO-[1,7]NAPHTHYRIDINE | J-516770 | EN300-1667031 | CS-0136420 | A822607 | MFCD11518971 | 5-BROMO-1,2,3,4-TETRAHYDRO-1,7-NAPHTHYRIDINE | SB73792 | SCHEMBL5518113 | AKOS016011741 | FT-0645415 | SY323177 | 5-bromanyl-
CAS No.351457-97-1
PubChem CID22352473

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACHBIM327 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHBIM327 route product structure diagram
    ACHBIM327351457-97-1 In Stock
Inquiry

2. ACHBIM327 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIJRP385 route compound structure diagram
    ACIJRP38517965-76-3 In Stock
  2. Then
  3. ACHBIM327 route product structure diagram
    ACHBIM327351457-97-1 In Stock
Inquiry

Comments (0)